XML 39 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities      
Net (loss) income $ (618,702) $ 937,664 $ 370,930
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization expense 143,516 193,356 239,998
Amortization of operating lease right-of-use assets 80,203 122,673 0
Total Chile impairment 790,229 940 13,110
Gain on sales and disposal of subsidiaries and property and equipment, net (22,756) (753,519) (292,108)
Loss (gain) on derivative instruments 25,980 (7,438) (89,143)
(Payments for) proceeds from settlement of derivative contracts (626) (8,772) 14,117
Loss on debt extinguishment 610 28,752 7,481
Non-cash interest expense 17,450 3,535 15,408
Interest paid on deferred purchase price for acquisitions (3,969) (5,305) (4,463)
Non-cash share-based compensation expense 13,298 12,994 10,791
Bad debt expense 117,867 100,829 112,440
Deferred income taxes (185,652) (29,813) (7,474)
Unrealized foreign currency exchange loss 26,344 29,186 37,796
Non-cash loss from non-income tax contingencies 3,059 9,075 6,839
Other, net 408 (5,341) (10,297)
Changes in operating assets and liabilities:      
Receivables (323,036) (163,202) (83,316)
Prepaid expenses and other assets (28,504) (42,047) (39,347)
Accounts payable and accrued expenses (47,200) 5,574 (7,512)
Income tax receivable/payable, net 99,563 (36,220) 48,875
Deferred revenue and other liabilities 171,474 (53,152) 52,733
Net cash provided by operating activities 259,556 339,769 396,858
Cash flows from investing activities      
Purchase of property and equipment (74,624) (155,641) (238,046)
Expenditures for deferred costs (14,538) (17,701) (19,866)
Receipts from sales of discontinued operations, net of cash sold, property and equipment and other 676,569 1,266,042 375,807
Settlement of derivatives related to sale of discontinued operations and net investment hedge 0 12,866 (9,960)
Proceeds from property insurance recoveries and corporate-owned life insurance 0 842 27,356
Business acquisitions, net of cash acquired 0 (1,205) (17,019)
Payments (to) from related parties and investments in affiliates (7) 84 (2,778)
Proceeds from sale of investment 0 11,473 0
Net cash provided by investing activities 587,400 1,116,760 115,494
Cash flows from financing activities      
Proceeds from issuance of long-term debt, net of original issue discount 528,382 1,123,179 485,470
Payments on long-term debt (705,353) (2,507,790) (867,915)
Payments of deferred purchase price for acquisitions (5,680) (20,157) (13,650)
Payments to purchase noncontrolling interests (13,716) (5,761) (127)
Payment of dividends on Series A Preferred Stock and to noncontrolling interests 0 0 (11,103)
Proceeds from exercise of stock options 25,716 14,007 0
Payments to repurchase common stock (99,523) (264,093) 0
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options (1,154) (2,245) (2,528)
Payments of debt issuance costs (779) (9,091) (587)
Distributions (to) from noncontrolling interest holders (609) (2,026) 311
Net cash used in financing activities (272,716) (1,673,977) (410,129)
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash (546) 5,070 8,998
Change in cash included in current assets held for sale 195,787 184,578 (109,546)
Net change in Cash and cash equivalents and Restricted cash 769,481 (27,800) 1,675
Cash and cash equivalents and Restricted cash at beginning of period 97,817 125,617 123,942
Cash and cash equivalents and Restricted cash at end of period $ 867,298 $ 97,817 $ 125,617